BridgeBio Pharma Shares Down 3% to $68.55
Shares of BridgeBio Pharma are down $2.17, or 3%, to $68.55, but have come off session lows as traders discuss the company reportedly having cancelled out of the UBS biotech summit conference, trading contacts tell The Fly.
